Literature DB >> 11823132

A new precursor for the radiosynthesis of [18F]FLT.

S J Martin1, J A Eisenbarth, U Wagner-Utermann, W Mier, M Henze, H Pritzkow, U Haberkorn, M Eisenhut.   

Abstract

In order to improve the [18F]FLT production for nuclear medical purposes, the syntheses and labeling results obtained with six new thymidine derivatives involving an alternative protection group strategy are described. The syntheses of the FLT-labeling precursors were performed using the following protection groups at the 5'-O-position: trityl (Tr) and 4,4'-dimethoxytrityl (DMTr). Formation of an electrophilic center at the 3'-carbon was achieved with methylsulfonyl, p-toluenesulfonyl and 4-nitrobenzenesulfonyl groups. The major difference to previous accomplishments rested upon the 3-N-Boc-protection of the FLT-labeling precursors avoiding the deprotection with ceric ammonium nitrate (CAN). With CAN, a precipitate was formed which was found to interact unfavourably with synthesis automation. Here, deprotection resulted in homogeneous solutions which could immediately be loaded on HPLC. The radiosyntheses were performed with high doses of [18F]fluoride to obtain realistic results for routine production of the clinically interesting radiopharmaceutical, [18F]FLT. It was shown that the nosylated precursors were more favorable for radiofluorination than the mesylated or tosylated derivatives. A positive effect on the radiochemical yield was found with DMTr in comparison to Tr. Best results were obtained using 3-N-Boc-1-[5-O-(4,4'-dimethoxytrityl)-3-O-nosyl-2-deoxy-beta-D-lyxofuranosyl]thymine yielding 1.7 GBq (19.8% EOB) whithin 85 minutes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11823132     DOI: 10.1016/s0969-8051(01)00289-x

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  22 in total

1.  Biomarker-Based PET Imaging of Diffuse Intrinsic Pontine Glioma in Mouse Models.

Authors:  Susanne Kossatz; Brandon Carney; Melanie Schweitzer; Giuseppe Carlucci; Vesselin Z Miloushev; Uday B Maachani; Prajwal Rajappa; Kayvan R Keshari; David Pisapia; Wolfgang A Weber; Mark M Souweidane; Thomas Reiner
Journal:  Cancer Res       Date:  2017-01-20       Impact factor: 12.701

2.  Uptake decrease of proliferative PET tracer 18FLT in bone marrow after carbon ion therapy in lung cancer.

Authors:  Mitsuru Koizumi; Tsuneo Saga; Masayuki Inubushi; Toshimitsu Fukumura; Kyosan Yoshikawa; Naoyoshi Yamamoto; Mio Nakajima; Toshio Sugane; Masayuki Baba
Journal:  Mol Imaging Biol       Date:  2011-06       Impact factor: 3.488

3.  Impact of the definition of peak standardized uptake value on quantification of treatment response.

Authors:  Matt Vanderhoek; Scott B Perlman; Robert Jeraj
Journal:  J Nucl Med       Date:  2012-01       Impact factor: 10.057

4.  Novel "Add-On" Molecule Based on Evans Blue Confers Superior Pharmacokinetics and Transforms Drugs to Theranostic Agents.

Authors:  Haojun Chen; Orit Jacobson; Gang Niu; Ido D Weiss; Dale O Kiesewetter; Yi Liu; Ying Ma; Hua Wu; Xiaoyuan Chen
Journal:  J Nucl Med       Date:  2016-11-22       Impact factor: 10.057

5.  Application of a whole-body pharmacokinetic model for targeted radionuclide therapy to NM404 and FLT.

Authors:  Joseph J Grudzinski; John M Floberg; Sarah R Mudd; Justin J Jeffery; Eric T Peterson; Alice Nomura; Ronald R Burnette; Wolfgang A Tomé; Jamey P Weichert; Robert Jeraj
Journal:  Phys Med Biol       Date:  2012-03-07       Impact factor: 3.609

6.  Fetal dose estimates for (18)F-fluoro-L-thymidine using a pregnant monkey model.

Authors:  Rachel M Bartlett; Robert J Nickles; Todd E Barnhart; Bradley T Christian; James E Holden; Onofre T DeJesus
Journal:  J Nucl Med       Date:  2010-01-15       Impact factor: 10.057

Review 7.  Fluorinated tracers for imaging cancer with positron emission tomography.

Authors:  Olivier Couturier; André Luxen; Jean-François Chatal; Jean-Philippe Vuillez; Pierre Rigo; Roland Hustinx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-06       Impact factor: 9.236

8.  Effects of ATRA combined with citrus and ginger-derived compounds in human SCC xenografts.

Authors:  Heather E Kleiner-Hancock; Runhua Shi; Angela Remeika; Delira Robbins; Misty Prince; Jennifer N Gill; Zanobia Syed; Patrick Adegboyega; J Michael Mathis; John L Clifford
Journal:  BMC Cancer       Date:  2010-07-26       Impact factor: 4.430

9.  Efficient radiosynthesis of 3'-deoxy-3'-18F-fluorothymidine using electrowetting-on-dielectric digital microfluidic chip.

Authors:  Muhammad Rashed Javed; Supin Chen; Hee-Kwon Kim; Liu Wei; Johannes Czernin; Chang-Jin C J Kim; R Michael van Dam; Pei Yuin Keng
Journal:  J Nucl Med       Date:  2013-12-23       Impact factor: 10.057

10.  Impact of different standardized uptake value measures on PET-based quantification of treatment response.

Authors:  Matt Vanderhoek; Scott B Perlman; Robert Jeraj
Journal:  J Nucl Med       Date:  2013-06-17       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.